Literature DB >> 7784021

Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging.

L L Subak1, H Hricak, C B Powell, L Azizi, J L Stern.   

Abstract

OBJECTIVE: To assess the accuracy of computed tomography (CT) and magnetic resonance imaging (MRI) in the evaluation of invasive cervical cancer.
METHODS: Seventy-nine women with untreated cervical cancer underwent pre-treatment MRI (n = 71) and/or CT (n = 37) within 4 weeks of surgical evaluation. Twenty-nine women had both MRI and CT. Images were evaluated for tumor detection, size, stromal invasion, local extension, and nodal metastases.
RESULTS: Tumor size was evaluated accurately by MRI, with a correlation coefficient of 0.93. Magnetic resonance estimates of tumor size were within 0.5 cm of the surgical sample in 64 of 69 women (93%). Magnetic resonance was 88% accurate evaluating the presence of stromal invasion and 78% accurate for depth of stromal invasion. Computed tomography could not evaluate tumor size or stromal invasion because it could not distinguish cancer from the surrounding normal cervical tissue. In evaluating stage of disease, MRI had an accuracy of 90%, compared with 65% for CT (P < .005). Magnetic resonance imaging was more accurate than CT (94 versus 76%, P < .005) in assessing parametrial invasion. Both modalities were comparable in evaluating lymph node metastases (86% each). In determining operative candidates (stage I and minimal IIA), MRI was 94% accurate, compared with 76% for CT (P < .005).
CONCLUSION: Compared with CT, MRI offered significantly improved evaluation of tumor size, stromal invasion, and local and regional extent of disease in pre-treatment imaging for cervical cancer.

Entities:  

Mesh:

Year:  1995        PMID: 7784021     DOI: 10.1016/0029-7844(95)00109-5

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  47 in total

1.  Efficacy of transvaginal contrast-enhanced MRI in the early staging of cervical carcinoma.

Authors:  Deniz Akata; Ulku Kerimoglu; Tuncay Hazirolan; Musturay Karcaaltincaba; Faruk Köse; Mustafa N Ozmen; Okan Akhan
Journal:  Eur Radiol       Date:  2005-01-27       Impact factor: 5.315

Review 2.  Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.

Authors:  Elly Brockbank; Fani Kokka; Andrew Bryant; Christophe Pomel; Karina Reynolds
Journal:  Cochrane Database Syst Rev       Date:  2011-04-13

Review 3.  Lymphotropic nanoparticle enhanced MRI for the staging of genitourinary tumors.

Authors:  Samdeep K Mouli; Lee C Zhao; Reed A Omary; C Shad Thaxton
Journal:  Nat Rev Urol       Date:  2010-01-19       Impact factor: 14.432

4.  Role of computed tomography (CT) scan in staging of cervical carcinoma.

Authors:  T V Prasad; S Thulkar; S Hari; D N Sharma; S Kumar
Journal:  Indian J Med Res       Date:  2014-05       Impact factor: 2.375

5.  Optimal MRI interval for detection of asymptomatic recurrence in surgically treated early cervical cancer by use of a mathematical model.

Authors:  A Laios; K Gubbala; R Lampe; A Tolis
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

6.  Sequential magnetic resonance imaging of cervical cancer: the predictive value of absolute tumor volume and regression ratio measured before, during, and after radiation therapy.

Authors:  Jian Z Wang; Nina A Mayr; Dongqing Zhang; Kaile Li; John C Grecula; Joseph F Montebello; Simon S Lo; William T C Yuh
Journal:  Cancer       Date:  2010-11-01       Impact factor: 6.860

Review 7.  Early Cervical Cancer: Current Dilemmas of Staging and Surgery.

Authors:  Tiffany Zigras; Genevieve Lennox; Karla Willows; Allan Covens
Journal:  Curr Oncol Rep       Date:  2017-08       Impact factor: 5.075

Review 8.  Clinical examination versus magnetic resonance imaging in the pretreatment staging of cervical carcinoma: systematic review and meta-analysis.

Authors:  Maarten G Thomeer; Cees Gerestein; Sandra Spronk; Helena C van Doorn; Els van der Ham; Myriam G Hunink
Journal:  Eur Radiol       Date:  2013-03-01       Impact factor: 5.315

Review 9.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

10.  Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy.

Authors:  Swamidas V Jamema; Sherly Saju; Umesh Mahantshetty; S Pallad; D D Deshpande; S K Shrivastava; K A Dinshaw
Journal:  J Med Phys       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.